Teva Pharmaceutical Industries Ltd
TEVA:NYSE
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
| 38.22 | 0.04 0.10% | 3.15% | 2,265,567 | 3.0M |
Market data is delayed by at least 20 minutes.
Latest News Headlines for Teva Pharmaceutical Industries Ltd
Teva Reports Top-Line Results from Final Phase III Study of Armodafinil (NUVIGIL(R)) in Patients with Major Depression Associated with Bipolar I Disorder
View more recent headlines
JERUSALEM--(BUSINESS WIRE)--August 30, 2013--
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced top-line results of its final Phase III clinical study for armodafinil (NUVIGIL(R) ) as adjunct therapy in adults with major depression associated with bipolar I disorder. The study reached statistical significance in several important secondary endpoints, such as responder rate and remission. However, it did not reach its primary endpoint --to determine whether armodafinil treatment (150mg per day) is more effective than placebo as adjunct therapy to mood stabilizers and/or atypical antipsychotics.
Company Background
Teva Pharmaceutical Industries Ltd (Teva) is an Israel-based pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. Teva's active pharmaceutical ingredient (API) business provides vertical integration to Teva's own pharmaceutical production. The Company's global operations are conducted from North and Latin America to Europe and Asia. Teva operates a number of subsidiaries in such countries as Canada, Croatia, the Czech Republic, France, Germany, Hungary, Ireland, Israel, Japan, Poland, the Russian Federation, Spain, the Netherlands, the United Kingdom and the United States.
Bid/Size -- / -- | Ask/Size -- / -- |
Price Open 38.37 | Previous Close 38.18 |
Day High 38.44 | Day Low 38.18 |
52wk High/Date 42.83 / 12/10/2012 | 52wk Low/Date 36.63 / 12/31/2012 |
% off 52wk High -10.76% | % off 52wk Low 4.34% |
Beta (5 Yr) 0.4 | Market Capitalization 32.5B |
Shares Outstanding 851.0M | Volatility Avg 16.89 |
EPS(TTM) 0.48 | P/E Ratio 79.4 |
Dividend Announcement 8/1/2013 | Dividend Yield 3.15% |
Ex-Date 8/16/2013 | Date of Record 8/20/2013 |
Payable 0.3219 - QRTR | Payable Date 9/3/2013 |
Last Trade as of 8/30/2013 4:07 PM ET | |
TEVA Teva Pharmaceutical Industries Ltd vs. Peers
| Peers | |
|---|---|
TEVA Teva Pharmaceutical Industries Ltd | 2.36% |
Momenta Pharmaceuticals, Inc. | 19.51% |
TEVA Teva Pharmaceutical Industries Ltd | 3.15% |
Momenta Pharmaceuticals, Inc. | -- |
TEVA Teva Pharmaceutical Industries Ltd | 0.10% |
Momenta Pharmaceuticals, Inc. | -1.61% |